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Abstract:  
 Due to the cause of recent outbreaks within regions of the United States and other parts of 
the world, the study of Elizabethkingia anophelis has been of great interest due to high mortality 
and presence of multiple antibiotic resistance mechanisms. Of the many different resistance 
mechanisms that E. anophelis can employ, the presence of multiple -lactamase enzymes has 
been of great interest for studies on the pathogenicity of this bacterium. Closely related to many 
of the other Elizabethkingia species, understanding the novel genes in both genomes and 
identifying the novel -lactamase genes is crucial in developing better diagnostic and treatment 
methods for Elizabethkingia infections.  
 
Introduction:  
Elizabethkingia Species and Characteristics:  
Elizabetkingia is a genus of bacteria with six characterized species. Discovered primarily 
as a branch from Flavobacteriaceae family branching from the Chryseobacterium genus, 
Elizabethkinga was first discovered in 2005 (9). Characterized as gram-negative, non-motile, 
non-spore forming rods, this new genus of bacteria, the use of 16s rRNA sequencing, whole 
genome sequencing, DNA-DNA Hybridization, phylogenetic studies and phenotypic tests have 
differentiated the Elizabethkingia genus from Chryseobacterium (2, 9, 11). The six species 
currently identified are E. menigoseptica, E. miricola, E. anophelis, E. bruuniana, E. ursingii, 
and E. occulta (5, 11).  E. menigoseptica being one of the first two Elizabethkinga species 
characterized within the genus has shown association with meningitis and septicemia (9). First 
isolated from a case of neonatal meningitis, E. meningoseptica still remains a cause of outbreaks 
and a bacterium of interest for comparative studies with other species within the genus. The 
second species identified it the Elizabethkingia genus is E. miricola, isolated from condensed 
water obtained from the Russian Mir Space Station (9). The next species identified is E. 
anophelis. Isolated in 2011, this bacterium was obtained from the midgut of mosquitos 
(Anopheles gambiae) (10). Prior to characterization of three new novel species, the 
Elizabethkingia species were characterized by 16s rRNA sequencing and DNA-DNA 
hybridization (11). Upon further analysis, other species within the Elizabethkingia genus were 
identified. Distinct from the E. miricola branch, E. bruuniana and E. ursingii were discovered 
using average nucleotide identity BLASTIN, DNA-DNA hybridization, and phylogenetic 
analysis (11). E. occulta was originally proposed as a strain of E. ursingii, but upon utilization of 
the average nucleotide identity BLASTIN and determination of the genome-to-genome distance, 
was correctly identified as a novel species (11). Further comparison of the strain first identified 
as species occulta with other strains from the CDC strain collection have lead to the proposal of 
two strains within the E. occulta species (11). The name thus implies that the occulta species was 
hidden in plain sight (11). All three of the novel species have nearly identical phenotypic 
characteristics that are shared among the entire Elizabethkingia, therefore phenotypic testing 
cannot be used to differentiate the different species within this genus (11). While most species 
share common characteristics, E. meingoseptica and E. anophelis have presented as opportunistic 
pathogens (1). In addition to the specific locations of isolation, many of the Elizabethkinga 
species have been isolated from the soil, water, air, and nosocomial environments, showing the 
abundance of this genus (1, 9, 10, 11). Most genomic discrimination methods involve 16s rRNA 
sequencing, but whole-genome sequencing has shown a potential for another novel species 
within the Elizabethkingia genus, but the new potential species has yet to be classified (5). 
Having shown significant prominence due to outbreak cases and increased resistance, 
understanding the resistance mechanisms exhibited by species within this genus can give a better 
understanding of how to treat infections caused by Elizabethkingia bacteria, as well as apply to 
other resistance mechanisms exhibited by similar types of bacteria. Understanding the 
pathogenicity and differences in related species has given insight in to the most recent outbreaks 
of E. anophelis. For example, discriminating between E. anophelis and E. menigoseptica is 
proving very difficult be means of shared 16s rRNA sequence similarity approximately at 99.3% 
(5) and many resistance genes shared between the two species (1).  
 
The Importance Behind E. anophelis study: 
Elizabethkingia anophelis has been a bacterium of interest in studying resistance 
mechanisms and viability in many different environments. Having many different strains, several 
genes for adaptation to environments, as well as, antibiotic resistance have been characterized 
with genomic studies. As mentioned, E. anophelis was isolated from the mid gut of mosquitos 
(Anopheles gambiae) (1, 5, 10). Living in the gut of A. gambiae, E. anophelis elicit a symbiotic 
relationship for the ability to use multiple metabolite sources, hemolysis activity, and resistance 
to harsh environments (1). Due to the diet of mosquitos, E. anophelis must be able to survive on 
a variety of sugar sources. To compensate for the variety of metabolite sources, E. anophelis 
have genes encoding for a variety of glycoside hydrolase enzymes, which are responsible for 
metabolizing a variety of polysaccharides (1).  
E. anophelis has shown observable resistance to several antibiotics, and studying the 
resistance genes has shown consistency with those observations (1). Within the genome, 
resistance genes that code for multi-drug efflux pumps have been identified from the resistance-
nodulation-division, major facilitator multidrug, and multidrug and toxic compound extrusion 
transporter families (1). In addition to the multi-drug efflux pumps encoded in the genome, 
transferase enzymes used to inactivate antibiotics are also coded for, specifically 
chloramphenicol acetyltransferase (3, 7) and aminoglycoside 6-adenyltansferase (3). Another 
major component to the resistance exhibited by E. anophelis are genes encoding for all classes of 
-lactamase enzymes, which degrade antibiotic, rendering the antibiotic ineffective (1). 
Acquisition of the -lactamase enzymes have shown to be conserved among the species, but also 
transferred across species through plasmids.  
E. anophelis has been of great interest in recent years due to outbreaks across the United 
States in Wisconsin, Illinois, and Michigan (3). Extending beyond the United States, there have 
also been a reported E. anophelis outbreaks in Singapore, Hong Kong, and parts of the Central 
African Republic (5, 6, 7). As previously mentioned, the pathogenic nature of E. anophelis has 
required further genomic classification to better identify the different species associated with the 
Elizabethkinga genus, but the actual functionality of the resistance genes within the genome of 
the various Elizabethkinga species has yet to be confirmed. The mechanism for transmission is 
not well understood and requires further insight for means of prevention in clinical settings.  
Modes of Antibiotic Resistance:  
 E. anophelis resistance genes code for several different modes of antibiotic resistance (1, 
7). Within the genome there are genes encoding for several classes of multidrug efflux-pumps, 
antibiotic transferase enzymes, and novel -lactamase enzymes (1, 3, 7). Due to the diversity in 
resistance mechanisms, E. anophelis can evade many defenses used to ward of infection via E. 
anophelis and survive in environments where antibiotics may be prominent. Antibiotic 
widespread use has contributed to the progression of these resistance mechanisms, as well as, the 
utilization of multiple resistance mechanisms in order to ward off as many modes of attack as 
possible. Here, efflux pumps and transferase enzymes are discussed, while beta-lactamase 
enzymes are discussed in the next section. Within the E. anophelis genome, multi-drug efflux 
pumps are coded fore in the resistance-nodulation-division (RND), major facilitator multidrug 
(MFS), and multidrug and toxic compound extrusion (MATE) families of efflux pumps (1). 
Most of the efflux pumps that are coded for are apart of the RND and MFS families though (1). 
RND pumps are responsible for pumping substrates such as heavy metals and toxic chemicals in 
order to maintain intracellular conditions (1). E. meningoseptica in particular has 5 putative 
novel operons for RND efflux pumps (19). The presence of putative novel RND efflux pump 
operons within E. meningoseptica implies that the presence of potential novel RND efflux pump 
operons in E. anophelis as well. Either through branching species, conjugation, or mutations, the 
novel efflux pumps may lead to increased resistance due to lack of target specificity. MFS pumps 
facilitate transport of an even broader range of substrates, including proteins, sugars, metabolites, 
and various drugs (1, 14). E. anophelis has shown resistance to fluroquinolones and heavy 
metals, which may attributable to the efflux pumps (2, 4). Another mode of antibiotic resistance 
conferred by transferase enzymes, specifically chloramphenicol acetyltransferase and 
aminoglycoside 6-adenyltransferase (3, 7). By attaching a functional group to an antibiotic, the 
antibiotic is unable to bind to the active site of the target, rendering the drug ineffective. 
Continued study of the E. anophelis genome for antibiotic resistance covalent modification 
genes, as well as antibiotic resistance efflux pumps, but further characterization of the novel 
putative genes coding for resistance mechanisms is required.  
 Mutations in genes encoding for antibiotic resistance can alter the binding affinity of 
certain drugs to antibiotic resistance enzymes, thus conferring antibiotic resistance (18). 
Alterations in gene expression and can make designing a drug to bind to a particular target very 
difficult due to the rapid nature that bacterial DNA can change. Beyond enzymes that code for 
antibiotic resistance, targets for antibiotics can also mutate, such as the gene coding for particular 
rRNA (18). Additionally, transformational and recombinatorial processes can form “mosaic” 
genes which can modify a potential target for antibiotics (18). In particular to E. anophelis 
outbreak strains, mutations in the mut genes were found to lead to inactivation of certain adenine 
glycosylase enzymes responsible for repairing DNA (3). This led to a hypermutative state, 
meaning the genome constantly mutates and leads to an alteration in the function of many 
different proteins coded for in the E. anophelis genome. Further investigation is required to 
identify mutational events associated with antibiotic resistances.  
 In addition to the coded mechanisms of antibiotic resistance, gram-negative cells confer a 
mode resistance by nature of gram negative cells. Due to the presence of the cell wall, gram 
negative cells are naturally less permeable due to the presence of the outer membrane (18). 
Having the double membrane as mentioned makes antibiotic targeting difficult, but gram-
negative cells can also regulate the entrance of certain materials into the periplasmic space by 
regulating the expression of porins (18). Because many antibiotics enter through porins, down-
regulation of porins or expression of more selective porins can be detrimental to effectively 
attacking gram-negative cells (18). 
 
-Lactamase Enzymes: 
Gram-negative bacteria can produce five types of -lactamase enzymes, all serving the 
function to inactivate antibiotic molecules. The general function that are shared among all -
lactamase enzymes is the ability to cleave the amid bond on the -lactam ring in order to render 
the antibiotic ineffective (13). Utilized by many different bacteria, -lactamase enzymes share 
common characteristics, but also have distinctions that allow segregation into four distinct 
classes and one class that is less characterized (13). With a wide range of antibiotics, different 
classes act on different types of antibiotics, contributing to the diversity of the -lactamase 
enzymes. In particular, each class has a specific type of antibiotic that they target, while the 
extended spectrum -lactamase enzymes can target several types of antibiotics (12).  
Based on Ambler’s classification guide, the four classes of -lactamase enzymes are 
classified on their phenotypic characteristics. Class A -lactamase enzymes are part of the serine 
beta-lactamase enzymes and exhibit penicillinase activity (15). Class A -lactamase enzymes can 
be coded chromosomally or transferred via horizontal gene transfer between bacteria (15). Class 
B -lactamase differ from all of the other classes of -lactamase enzymes by means of identity at 
the active site (15). Class B enzymes are classified as the metallo--lactamses enzymes and are 
distinctive in their carapenenemase activity. Requiring zinc molecules for coordination at the 
active site, the enzymatic mechanism is completely different from that of the serine classes of -
lactamases (8). Class B -lactamases are largely chromosomally encoded (15). Class C enzymes 
are apart of the serine class of -lactamase enzymes and are characterized by their 
cephalosporinase activity (15). Generally, class C -lactamase enzymes are chromosomally 
encoded (15). Lastly, there is the class D -lactamase enzymes, which are apart of the serine 
class of -lactamase enzymes and are characterized by their oxacillin-hydrolase activity (15). 
Class D -lactamases can be both chromosomally encoded and plasmid acquired (15). The last 
classification of -lactamase enzymes is less well-defined. Extended spectrum -lactamase 
enzymes are responsible for resistance to multiple classes of antibiotics, specifically several 
classes of penicillins, third generation cephalosporins, and aztreonam (12). Encompassing a 
broader range of -lactamase enzymes, the extended-spectrum -lactamase enzymes are not as 
well characterized as the other classes. 
Because many -lactamase enzymes are acquired via horizontal gene transfer among 
bacteria, many of the associated resistance mechanisms can also be associated with acquisition of 
other resistance genes, whether that be resistance acquired by plasmids or other resistance 
mechanisms that could be utilized for further drug resistance and survival. By identifying the 
novel -lactamase enzymes and by obtaining a better understanding of the resistance 
mechanisms exhibited by the different species within the Elizabethkingia genus, better diagnostic 
methods can be developed along with better treatment methods for approaching outbreaks. 
Because E. meningoseptica and E. anophelis share many characteristics and share many genes, 
developing better discrimination methods is crucial for identifying the source of infection. 
Having been discovered first, many of the E. meningoseptica class B -lactamase enzymes have 
previously been classified, but novel -lactamase genes still exist in many of the Elizabethkingia 
genomes, and classification of the novel genes and further study is required for future 
classification and for future targeting.  
 
-Lactam Antibiotics Mode of Action: 
Mechanistically, all of the -lactam class antibiotics function in identical ways.  For the 
Penicillin class of antibiotics, the target is the cell wall. Penicillin antibiotics are responsible for 
inhibiting the synthesis of the peptidoglycan within in the cell wall, ultimately causing cell lysis 
due to a compromised cell wall and the effects of osmotic pressure on the cell wall (16). This is 
done via targeting and binding penicillin to the transpeptidase enzymes responsible for cross-
linking the peptidoglycan layer within the cell wall (16). Residing in the class of -lactam 
antibiotics, both carbepenems and cephalosporins have identical mechanisms, but with different 
efficiencies from the penicillin classes of antibiotics. The major differences between the different 
classes of -lactam antibiotics is the shape of the molecule itself, making the different classes of 
-lactamase enzymes specific for the specific molecule shape.  
 
 
 
 
Methods and Materials:  
In order to understand the functional nature of one of the novel -lactamase genes in the 
E. anophelis genome, cloning of the TLA-1 Homolog gene (Bla3533) was required, where future 
protein purification and functionality tests will continue after optimal cloning has been 
performed. Using plasmid DNA with the insert of bla3533, the plasmid DNA was grown 
overnight at room temperature. The next day a plasmid miniprep was done in order to clean up 
and isolate the plasmid DNA. Using the plasmid DNA, polymerase chain reaction trials set up 
according to table one were conducted in order to find optimal conditions for PCR trials. After 
every run, the PCR product was checked on a 1% agarose gel for identification of proper band 
size. Following the isolation of 7-8 successful PCR trials, the PCR product was cleaned up using 
the Enoch PCR clean-up kit following the given procedures within the clean-up kit. With 
isolated PCR product, restriction digests using BAMH1 and SAC1 restriction enzymes. 
Restriction digests were done on both the purified PCR product and pSKB3 vector, which were 
ligated together following the heat-killed restriction digests. After ligation of the target gene into 
the digested pSKB3 vector, the plasmid is then transformed into DH5 competent cells. The  
transformed cells were grown on Kanamycin plates and observed for colony growth.  
  
Reagent Tube 1 Tube 2 Tube 3 Tube 4 
Water 32 30.5 30.5 29 
5X phusion buffer 1 1 1 1 
10mM dNTPs 1 1 1 1 
Template 1 1 1 1 
10uM for Primer 2.5 2.5 2.5 2.5 
10 uM Rev Primer 2.5 2.5 2.5 2.5 
DMSO 0 1.5 0 1.5 
50mM MgCl2 0 0 1.5 1.5 
Taq 0.5 0.5 0.5 0.5 
Table 1: PCR protocol. All of the values listed in the table are in in L 
Figure 1: PCR trial confirmation on 1% agarose gel. 
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Results:  
While the cloning project progressed passed the isolation of the targeted DNA sequence 
via polymerase chain reaction, successful clones were not able to be isolated passed the 
transformation step. Figure 1 shows the result of the PCR trials, with faint bands around 900 base 
pairs, the size of the gene. Past the PCR trials, the restriction digested vector and PCR products 
were successfully ligated (Figure 2). Upon the transformation step into competent cells, 0 
colonies were isolated from any of the incubated plates with Kanamycin. This implies that the 
Kanamycin plates may have been to concentrated with Kanamycin, meaning all the cell growth 
was susceptible to the antibiotic. We could not effectively identify if the plasmid transformed 
due to the lack of growth on the plates, again, attributable to potential error in the Kanamycin 
plate concentrations.  
 
Discussion:   
Due to the presence of various Elizabethkinga outbreaks around the world, further 
genomic classification of the antibiotic resistance mechanisms and varying Elizabethkinga 
species is required for better targeting in clinical settings. Due to the abundance of this genus 
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Figure 2: DNA ligation step. The PCR product (approximately 1000 bp) was 
ligated into the pSKB3 vector 
throughout a range of environments, fully understanding the pathogenicity of species within this 
genus is important for understanding treatments. With many of the Elizabethkinga species 
sharing up to 99.8% homology among genomic sequences, misidentification of species and 
improper targeting have made finding a treatment very difficult (5).  Specifically, E. anophelis 
has been a bacterium of interest due to the large Wisconsin outbreak in 2015 and 2016, the 
outbreaks in Central Africa and the outbreaks in Singapore (5, 6, 7). Understanding novel 
resistance mechanisms and understanding the natural resistance that this bacterium utilizes is 
crucial. Housing many novel -lactamase genes, further classification of the -lactamase genes is 
important for expansion of antibiotic development and multi-drug antibiotic treatments.  
While cloning the Ag1 3533 gene proved unsuccessful in this particular experiment, 
further cloning projects can identify the genes that code for -lactamase enzymes as well as 
classify and identify proper functionality. Because of the abundance of novel genes that exist 
within the Elizabethkingia genus, cloning of the putative -lactamase genes and protein studies 
can help understanding the pathogenicity associated with E. meningoseptica and E. anophelis.  
 
Future Directions:  
In the future, the project must be repeated from the plasmid prep step of the plasmid 
DNA with the isolated gene of interested. The plasmid prep step should be re-isolated and the 
cloning project must be redone prior to analyzing the functionality of the beta-lactamase enzyme. 
Following all of the standard steps required for cloning, a positive clone must be isolated and 
sequenced to ensure isolation of the correct gene. Following a successful sequence step, 
transformations of the plasmid into DH5 cells and additionally BL21 cells will allow more 
variety for future functional testing and protein work. Small and large Kirby-Bauer assays can 
then be done in order to test antibiotic susceptibility to different types of antibiotics. Following 
the standard protocol for the Kirby-Bauer assays will allow analysis of the different types of 
antibiotics that this specific beta lactamase enzyme is susceptible to and allow measurement of 
how susceptible the enzyme is to particular antibiotics. Moving past Kirby-Bauer assays, 
minimum inhibitory concentration procedures can be done in order to determine the minimum 
concentration of antibiotic used to inhibit the growth of E. anophelies. This is another test that 
can be used to determine the susceptibility of this particular bacterium to various concentrations 
of antibiotic and different types of antibiotic. After testing various reactions to antibiotics, 
functionality of the beta-lactamase enzyme can be further analyzed. Protein purification must be 
conducted in order to isolate the protein for functional tests. No protocols have been developed, 
so optimizing a protocol for the protein purification step is required for further investigation. 
Following protein purification, various enzyme assays can be used to determine some of the 
functional features associated with the Ag1 3533 gene expression of the subsequent -lactamase 
enzyme. Protocols for the enzyme assays have not been developed and require the development 
and optimization in order to be used. In addition to this gene, there are still many novel genes 
within the E. menigoseptica and E. anophelis genome that need further identification.  
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